Secure shopping
Healthcare and pharma
The Pharma & Healthcare industry is of vital importance for human and economic development, providing a wide range of goods and services relevant to the promotion of health at all stages in the healthcare process – from prevention and treatment to rehabilitation and palliative care. It is one of the fastest-growing industries, supported by profound demographic changes, the rising incidence of non-communicable diseases, and surging per capita health spending in both developed and emerging markets. The industry is also one of the major innovators, with increasing expenditures on development of new molecules, biotechnology and adoption of new technologies that provide advanced healthcare and ensure the longevity of the population.
The Pharma & Healthcare industry comprises the manufacture of pharmaceuticals for human and veterinary use, medical equipment and related supplies. It also includes providers of ambulatory health services, medical and diagnostic laboratories, hospitals, and nursing and residential care facilities.
In Q3 2017 China continued to implement healthcare reforms which resulted in further development and growth of the sector. According to a health management summit held in Beijing in late 2017, the country’s healthcare market will reach RMB 4 ...
View more details
China's healthcare system is hospital-centric, with public hospitals delivering approximately 90% of the inpatient and outpatient care consumed in the country in both hospitals and basic medical institutions. Nearly 40% of hospitals’ revenue is ...
View more details
The pharmaceutical sector in the Czech Republic generated a gross value added (GVA) of CZK 18.9bn in 2016, up by 8.2% y/y in real terms. It accounted for 0.44% of the total GVA in the economy in 2016. The sector employed 9,438 workers. Total ...
View more details
Brazil is the eighth-largest pharmaceutical market in the world. In 2016, the retail drug market, based on ex-factory prices, rose by 15.5% y/y to BRL 87.2bn, supported by upward price dynamics and steady demand for innovative patented drugs. In ...
View more details
China's healthcare system is hospital-centric, with public hospitals delivering approximately 90% of the inpatient and outpatient care consumed in the country in both hospitals and basic medical institutions. Nearly 40% of hospitals’ revenue is ...
View more details
India’s 1.3-bn population has given rise to a sizeable healthcare sector and one of the largest pharmaceutical markets in Asia. Both the healthcare and drug markets are plagued by uneven geographical spread, low levels of public expenditure and ...
View more details
China's healthcare system is hospital-centric, with public hospitals delivering approximately 90% of the inpatient and outpatient care consumed in the country in both hospitals and basic medical institutions. Nearly 40% of hospitals’ revenue is ...
View more details
The Philippines healthcare and pharmaceuticals sector has grown gradually in past years due to the country’s population and economic growth. Recently, sector growth has accelerated due to policy measures to increase the healthcare budget which ...
View more details
Indonesia's healthcare and pharmaceuticals industry is one of the least developed in ASEAN and Indonesia has low scores on most metrics – including number of hospitals and beds per 10,000 population and healthcare expenditure per capita. These ...
View more details
The Malaysian healthcare and pharmaceuticals sector has been growing strongly as a result of factors including one of the highest population growth rates in the ASEAN region, increasing affluence, and growing access to healthcare funding. In ...
View more details